Colin C. Collins

Active 1987–2025

129
Papers
26,320
Citations
80
h-index
124
i10-index

Citations

Citations per year for Colin C. Collins1955: 1 citations1976: 3 citations1980: 1 citations1987: 1 citations1988: 3 citations1989: 6 citations1990: 25 citations1991: 16 citations1992: 39 citations1993: 34 citations1994: 21 citations1995: 35 citations1996: 32 citations1997: 49 citations1998: 67 citations1999: 105 citations2000: 157 citations2001: 194 citations2002: 208 citations2003: 240 citations2004: 286 citations2005: 301 citations2006: 311 citations2007: 221 citations2008: 198 citations2009: 214 citations2010: 196 citations2011: 184 citations2012: 165 citations2013: 165 citations2014: 146 citations2015: 152 citations2016: 248 citations2017: 287 citations2018: 344 citations2019: 872 citations2020: 848 citations2021: 916 citations2022: 616 citations2023: 418 citations2024: 685 citations2025: 286 citations2026: 7 citations1956–1975: no citations, so these years are not shown1977–1979: no citations, so these years are not shown1981–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,727 citing papers, 31.8% of this breakdownChina: 1,371 citing papers, 11.7% of this breakdownUnited Kingdom: 810 citing papers, 6.9% of this breakdownCanada: 743 citing papers, 6.3% of this breakdownGermany: 562 citing papers, 4.8% of this breakdownItaly: 420 citing papers, 3.6% of this breakdownJapan: 324 citing papers, 2.8% of this breakdownAustralia: 318 citing papers, 2.7% of this breakdownFrance: 299 citing papers, 2.6% of this breakdownNetherlands: 299 citing papers, 2.5% of this breakdownSwitzerland: 218 citing papers, 1.9% of this breakdownSpain: 205 citing papers, 1.7% of this breakdown
0%31.8%Other 20.7%

Fields

  • Biochemistry, Genetics and Molecular Biology56.2%
  • Medicine36.1%
  • Agricultural and Biological Sciences1.7%
  • Computer Science1.1%
  • Immunology and Microbiology1%
  • Neuroscience1%
  • Other2.9%

Topics

  • Prostate Cancer Treatment and Research6%
  • Cancer Genomics and Diagnostics4.7%
  • Genomic variations and chromosomal abnormalities3.8%
  • Cancer-related molecular mechanisms research2.8%
  • RNA modifications and cancer2.4%
  • Prostate Cancer Diagnosis and Treatment2.3%
  • Other78%

Coauthors

All papers

Open in search
  1. Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 1,020

  2. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 cited by 444

  3. Genomic hallmarks of localized, non-indolent prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lee E. Timms, Nicholas Buchner, Michèle Orain, Valérie Picard, Hélène Hovington, Alexander Murison, Ken J. Kron, Nicholas J. Harding, Christine P’ng, Kathleen E. Houlahan, Kenneth C. Chu, Bernard Lo, Francis Nguyen, Constance H. Li, Ren Sun, Richard de Borja, Christopher I. Cooper, Julia F. Hopkins, Shaylan K. Govind, Clement Fung, Daryl Waggott, Jeffrey J. Green, Syed Haider, Michelle Chan‐Seng‐Yue, Esther Jung, Zhiyuan Wang, Alain Bergeron, Alan Dal Pra, Louis Lacombe, Colin C. Collins, Cenk Sahinalp, Mathieu Lupien, Neil Fleshner, Housheng Hansen He, Yves Fradet, Bernard Têtu, Theodorus van der Kwast, John D. McPherson, Robert G. Bristow, Paul C. Boutros - Nature 2017 cited by 641

  4. Widespread and Functional RNA Circularization in Localized Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Lacombe, Yves Fradet, Bernard Têtu, Stanley K. Liu, Felix Y. Feng, Xue Wu, Yang Shao, Malgorzata A. Komor, Cenk Sahinalp, Colin C. Collins, Youri Hoogstrate, Mark de Jong, Remond J.A. Fijneman, Teng Fei, Guido Jenster, Theodorus van der Kwast, Robert G. Bristow, Paul C. Boutros, Housheng Hansen He - Cell 2019 cited by 696

  5. The Proteogenomic Landscape of Curable Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 278

  6. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 1,105

  7. Spatial genomic heterogeneity within localized, multifocal prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephenie D. Prokopec, Jenna Sykes, Alan Dal Pra, Alejandro Berlín, Andrew Brown, Michelle Chan‐Seng‐Yue, Fouad Yousif, Robert E. Denroche, Lauren C. Chong, Gregory M. Chen, Esther Jung, Clement Fung, Maud H. W. Starmans, Hanbo Chen, Shaylan K. Govind, James R. Hawley, Alister D’Costa, Melania Pintilie, Daryl Waggott, Faraz Hach, Philippe Lambin, Lakshmi Muthuswamy, Colin Cooper, Rosalind A. Eeles, David E. Neal, Bernard Têtu, Cenk Sahinalp, Lincoln Stein, Neil Fleshner, Sohrab P. Shah, Colin C. Collins, Thomas J. Hudson, John D. McPherson, Theodorus van der Kwast, Robert G. Bristow - Nature Genetics 2015 cited by 489

  8. Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?

    Authors: , , , - The Journal of Pathology 2013 cited by 345

  9. Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 479

  10. Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - JAMA Oncology 2016 cited by 384

  11. Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

    Authors: , , , - Molecular Cancer Research 2016 cited by 357

  12. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

    Authors: , , , , , , , , , , , , , , , - Nature Genetics 1997 cited by 1,286

  13. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank J. Slack, Elai Davicioni, Himisha Beltran, Colin C. Collins, Andrew S. Kraft - Nature Communications 2021 cited by 104

  14. Out-of-distribution generalization from labelled and unlabelled gene expression data for drug response prediction

    Authors: , , , , - Nature Machine Intelligence, Nat. Mach. Intell. 2021 cited by 40

  15. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meng Qiao, Hang-Mao Lee, Yuehong Yang, Yasheng Zhu, Xiaolei Shi, Rui Chen, Yang Wang, Weidong Xu, Yan‐Qiong Cheng, Chuanliang Xu, Xu Gao, Tie Zhou, Bo Yang, Jianguo Hou, Li Liu, Zhensheng Zhang, Yao Zhu, Chao Qin, Pengfei Shao, Jun Pang, Leland W.K. Chung, Jianfeng Xu, Chin‐Lee Wu, Weide Zhong, Xun Xu, Yingrui Li, Xiuqing Zhang, Jian Wang, Huanming Yang, Jun Wang, Haojie Huang, Yinghao Sun - European Urology 2017 cited by 200

  16. High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2013 cited by 365

  17. Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer

    Authors: , , , , , , , - BMC Genomics 2019 cited by 124

  18. Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , - iScience 2022 cited by 61

  19. The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2015 cited by 301

  20. Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 164

  21. Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients

    Authors: , , , , , , , , , , , , , , - Genome biology 2016 cited by 212

  22. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition

    Authors: , , , , , , , , , , , - European Urology 2016 cited by 181

  23. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Igor Jurišica, Colin Cooper, Rosalind A. Eeles, Melania Pintilie, Alan Dal Pra, Elai Davicioni, Wan L. Lam, Michael Milosevic, David E. Neal, Theodorus van der Kwast, Paul C. Boutros, Robert G. Bristow - The Lancet Oncology 2014 cited by 351

  24. Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yinghao Sun, Yuzhuo Wang, Colin C. Collins, Yuzhuo Wang, Colin C. Collins - European Urology 2017 cited by 78